NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Wednesday, May 22, 2013
Vice Dean of Medicine Administration
Professor of Molecular Virology, Immunology & Medical Genetics
Professor of Veterinary Biosciences
Associate Vice President of Health Sciences Research Administration
Division of Pulmonary, Allergy, Critical Care & Sleep Medicine
Department of Internal Medicine
College of Medicine
The Ohio State University
Clay Marsh, MD, is a physician-scientist who is expert in translational research and who serves as the Director of the Center for Critical Care Medicine, Director, Pulmonary, Allergy, Critical Care and Sleep Medicine, Vice Chair, Research, Department of Internal Medicine and Deputy Director of the Davis Heart and Lung Research Institute. Dr. Marsh has authored over 50 manuscripts in high impact peer reviewed journals and is a recognized leader in pulmonary and critical care medicine nationally and has led the program at OSU to a 19 national ranking in US News and World Report. He is an elected member of the prestigious American Society of Clinical Investigation and is the chair-elect of the Stanly Sarnoff Endowment for Cardiovascular Sciences, an organization of leading cardiovascular physician-scientists in the nation, and is the only non-cardiologist to be elected to this position. He has been listed multiple times to America’s Best Doctors list, providing the background of translational science and clinical medicine to optimize the patient-related impact of the program. |
Dr. Marsh is currently the PI for three NIH grants and a Co-Investigator on an additional five NIH grants. His laboratory focuses on the role of mononuclear phagocytes in inflammation and disease models with focus on lung disease, transplantation and breast cancer. He is the PI for the pending Wright Center for Innovation Proposal to the State of Ohio (requested $28M from the state) in personalized medicine, a $20M NIH SCCOR proposal on the role of stress and depression and its role in innate immunity and chronic lung disease and a $6M program in personalized medicine in lung cancer. Dr. Marsh is the recognized leader in the application of personalized healthcare in the patient care environment.
More about Dr. Clay Marsh